FTRE (Fortrea Holdings Inc.) חוב לטווח קצר להון
Fortrea Holdings Inc. (FTRE) possesses limited pricing power, while its competitive advantage lies in conducting global early-stage drug trials. The business relies on an extensive network of global centers and immense experience in implementing medical innovations. This price chart on GURU.Markets shows the value of the 0.09 metric, and long-term agreements with biotech firms sustain demand despite partial saturation of the US market.
פילוחים אנליטיים של חברת Fortrea Holdings Inc.
This indicator measures the degree of equity dependence on liabilities maturing within one year, allowing for an assessment of liquidity risks amid changes in borrowing costs. By analyzing the ratio of current loans to equity, an investor can gauge the financial stability of Fortrea Holdings Inc. (FTRE), whose reputation as a premium partner in clinical research ensures access to stable financing even under a high debt load.